Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

364
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
364
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

123
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
123
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

169
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
169
Biostatistics: Overview01:20

Biostatistics: Overview

239
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
239

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multi-trait polygenic risk score enhances osteoporosis risk prediction in East Asian population.

Journal of advanced research·2026
Same author

Loneliness, traditional risk factor control, genetic predisposition, and development of musculoskeletal disorders.

Rheumatology (Oxford, England)·2026
Same author

The Flexible Sound Source.

ACS applied materials & interfaces·2026
Same author

Diradical-featured <i>N</i>-arene croconaine-based nanoagent for synergistic photodynamic/photothermal tumor therapy.

Journal of materials chemistry. B·2026
Same author

EXPRESS: Advances in artificial intelligence for neuroimaging.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026
Same author

Changes in frailty and incident risk of degenerative bone and joint diseases and their multimorbidity: a prospective cohort study.

Frontiers in public health·2026

Related Experiment Video

Updated: Jun 28, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

2.9K

Identifying and overcoming COVID-19 vaccination impediments using Bayesian data mining techniques.

Bowen Lei1, Arvind Mahajan2, Bani Mallick3

  • 1Department of Statistics, Texas A&M University, College Station, TX, USA.

Scientific Reports
|April 13, 2024
PubMed
Summary
This summary is machine-generated.

This study identifies reasons for COVID-19 vaccine hesitancy using health insurance data. It proposes strategies to overcome barriers, aiming to reduce mortality and economic impact.

More Related Videos

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

10.1K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

168

Related Experiment Videos

Last Updated: Jun 28, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

2.9K
Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

10.1K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

168

Area of Science:

  • Public Health
  • Health Economics
  • Data Science

Background:

  • The COVID-19 pandemic significantly impacted global health and economies.
  • Vaccine development offered a path to normalcy, but vaccination barriers persist.
  • Obstacles to vaccination have resulted in considerable mortality and economic strain.

Purpose of the Study:

  • To analyze factors contributing to vaccine hesitancy and refusal.
  • To identify at-risk populations affected by vaccination barriers.
  • To propose mitigation strategies and estimate associated cost savings.

Main Methods:

  • Utilized Bayesian data mining techniques for dimensionality reduction.
  • Identified key variables influencing vaccination decisions.
  • Employed comparative analysis to evaluate method performance against alternatives.

Main Results:

  • The study successfully pinpointed specific population groups facing vaccination challenges.
  • Bayesian data mining proved effective in identifying significant factors related to vaccine decisions.
  • The proposed methodology demonstrated superior performance compared to existing approaches.

Conclusions:

  • Understanding and addressing vaccine hesitancy is crucial for public health.
  • Data-driven strategies can effectively mitigate vaccination barriers.
  • Implementing these strategies can lead to significant economic benefits and lives saved.